KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Exact Sciences (EXAS) over the last 17 years, with Q4 2025 value amounting to $166.9 million.

  • Exact Sciences' Net Cash Flow rose 96394.52% to $166.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $348.5 million, marking a year-over-year increase of 13655450.98%. This contributed to the annual value of $348.5 million for FY2025, which is 13655450.98% up from last year.
  • Latest data reveals that Exact Sciences reported Net Cash Flow of $166.9 million as of Q4 2025, which was up 96394.52% from $131.9 million recorded in Q3 2025.
  • Exact Sciences' 5-year Net Cash Flow high stood at $309.4 million for Q2 2025, and its period low was -$740.1 million during Q2 2021.
  • Its 5-year average for Net Cash Flow is -$26.7 million, with a median of $19.9 million in 2022.
  • As far as peak fluctuations go, Exact Sciences' Net Cash Flow tumbled by 2585114.82% in 2021, and later skyrocketed by 96394.52% in 2025.
  • Exact Sciences' Net Cash Flow (Quarter) stood at $41.7 million in 2021, then crashed by 90.45% to $4.0 million in 2022, then skyrocketed by 222.0% to $12.8 million in 2023, then increased by 22.4% to $15.7 million in 2024, then skyrocketed by 963.95% to $166.9 million in 2025.
  • Its last three reported values are $166.9 million in Q4 2025, $131.9 million for Q3 2025, and $309.4 million during Q2 2025.